
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition
Description
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition
By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually. This should not be surprising. Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing. In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in 2020. The number of new tests for POC COVID-19 was stunning.
Updated for COVID-19 Impacts
In some segments, COVID-19 caused a contraction of the segment due to lockdown, closures, limited physician visits and a reduction in elective and outpatient surgery. The market is expected to resume pre-pandemic growth in all segments of the POC market. Certain segments will continue to advance significantly from 2021-2025. In 2025, the total global POC diagnostic testing market is expected to reach almost $45 billion, displaying growth of 8.9% over the forecast period 2020-2025.
It’s not all upside – test cost will continue to weigh more heavily upon the trajectory of POC testing in many markets. In Europe, fee schedules have significantly dampened or led to the contraction of national POC markets; Switzerland is an exception through its preserved (though repeatedly contested) premiums paid to POC tests over scheduled base fees. In the United States, future changes to Medicare’s CLFS will place significant pressure on some POC tests performed in large volumes on automated systems in centralized and commercial labs. These challenges and expected forecasts given their presence are discussed in the report.
Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinic. Other terms used to describe POC testing include near-patient testing, physician’s office laboratory (POL) testing, rapid testing, patient self-testing or patient self-management, bedside testing, remote testing, or satellite testing. Some of these alternate terms actually describe segments of the POC testing market. POC tests are performed in a wide range of geographical locations such as:
The menu for point-of-care testing continues to expand. The traditional set of POC tests includes blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening.
In the past 5-10 years the following tests were added: HbA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP). The future holds even more advancement of POC tests and devices including tests for cancer, molecular assays and phone enabled tests of all kinds.
Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care; especially since new technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation, or an electronic medical record.
This report breaks out point of care testing by segment.
Among the top and/or innovative competitors discussed within Corporate Profiles are:
By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually. This should not be surprising. Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing. In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in 2020. The number of new tests for POC COVID-19 was stunning.
Updated for COVID-19 Impacts
In some segments, COVID-19 caused a contraction of the segment due to lockdown, closures, limited physician visits and a reduction in elective and outpatient surgery. The market is expected to resume pre-pandemic growth in all segments of the POC market. Certain segments will continue to advance significantly from 2021-2025. In 2025, the total global POC diagnostic testing market is expected to reach almost $45 billion, displaying growth of 8.9% over the forecast period 2020-2025.
- Global POC Test Market, 2020-2025 (in millions $ at manufacturer level)
- Global POC Testing Market Analysis by Product Category, 2020 (in millions $) (Self-Testing, Professional Testing, Total)
- Global POC Self-Testing Market Analysis by Product Category, 2020 (in millions$) (Glucose [includes CGM], Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine, Infectious Disease, Lipid, Total)
- Global POC Self-Testing Market Analysis by Product Category, 2020 (by %) (Infectious Disease, Urine, DOA, Coagulation, FOB, Pregnancy, Glucose)
- Global POC Professional Testing Market Analysis by Product Subcategory, 2020 (in millions$) (Drugs of Abuse, Glucose includes HbA1c, Blood & Electrolytes, Infectious Disease, Rapid Coagulation, Fecal Occult Blood, Cardiac Markers, Lipid, Pregnancy & Fertility, Miscellaneous, Urine, Cancer Tumor Markers, Total)
- Global POC Professional Testing Market Analysis by Product Subcategory, 2020 (by %) (Tumor Markers, Urine, Misc, Pregnancy, Lipid, Cardiac Markers, Rapid Coag, FOB, Infectious Disease, Blood/ Electrolytes, Glucose/ HbA1c, DOA)
- POC Testing by End-user, 2020 (%) (Hospitals, Others)
- Global POC Market by Technology by Sales, 2020 (%) (LFA, Biosensors, Analyzers, Strips)
- Regional Market Analysis
- Global POC Testing Analysis by Region/Country, 2020 (in millions $) (United States, Europe, Japan, ROW, Total)
- Global POC Testing Market Analysis by European Region, 2020 (in millions $) (W. Europe, E. Europe, Total)
- Europe POC Testing Percentage Participation, by Country, 2020 (Germany, UK, France, Italy, Switzerland/ Sweden, Spain, Other)
- Global POC Testing Market Analysis by Rest of World Region/Country, 2020 (in millions $) (Latin America and Mexico, China, Australia, South Korea, India, Other, Total)
- POC Blood Glucose Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Blood and Electrolytes Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Rapid Coagulation Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Rapid Cardiac Markers Testing Regional Market Analysis, 2020 (US; Europe; Japan; Latin America, India, Asia Pacific and the Middle East; RoW)
- POC Substance Abuse Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Pregnancy and Fertility Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Infectious Disease Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Lipid Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Cancer Tumor Marker Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Urine Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Miscellaneous Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- Segment Size and Growth
- Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Diabetes Sales by Test Category, 2020-2025 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
- Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2020-2025 (in millions $ at manufacturer level)
- Global POC Continuous Glucose Self-Testing Market 2020-2025 (in millions $ at manufacturer level)
- Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2020-2025 (in millions $ at manufacturer level)
- Global POC Glucose HbA1c Professional Testing Market 2020-2025 (in millions $ at manufacturer level)
- Global POC Blood and Electrolytes Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Blood & Electrolytes Revenues by Test Category, 2020-2025 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
- Global POC Blood & Electrolytes Sales by Test Category, 2020-2025 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
- Global Rapid Coagulation Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Total Rapid Cardiac Markers Tests Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Drugs of Abuse Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Drugs of Abuse Self Testing Market, 2020-2025 (includes continuous glucose devices)
- Global POC Drugs of Abuse Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Pregnancy and Fertility Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Pregnancy and Fertility Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Pregnancy and Fertility Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Infectious Disease Testing Market Analysis: 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2020 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
- POC Infectious Disease Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Infectious Disease Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2018 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
- Global POC Lipid Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Lipid Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Lipid Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Cancer Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Urine Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Urine Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Urine Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global Miscellaneous POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Miscellaneous Sales by Test Category, 2020-2025 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions) (Microbiology, TSH, Allergy, Autoimmune, Others, Total)
It’s not all upside – test cost will continue to weigh more heavily upon the trajectory of POC testing in many markets. In Europe, fee schedules have significantly dampened or led to the contraction of national POC markets; Switzerland is an exception through its preserved (though repeatedly contested) premiums paid to POC tests over scheduled base fees. In the United States, future changes to Medicare’s CLFS will place significant pressure on some POC tests performed in large volumes on automated systems in centralized and commercial labs. These challenges and expected forecasts given their presence are discussed in the report.
Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinic. Other terms used to describe POC testing include near-patient testing, physician’s office laboratory (POL) testing, rapid testing, patient self-testing or patient self-management, bedside testing, remote testing, or satellite testing. Some of these alternate terms actually describe segments of the POC testing market. POC tests are performed in a wide range of geographical locations such as:
- Hospital departments such as emergency departments, operating rooms, intensive care units, and others
- Physicians’ offices
- Hospital clinics
- Rural health clinics
- Student health clinics
- Retail clinics
- Pharmacies
- Homes – With testing performed by patients, visiting nurses, or other caregivers
- Nursing homes
- Prisons
The menu for point-of-care testing continues to expand. The traditional set of POC tests includes blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening.
In the past 5-10 years the following tests were added: HbA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP). The future holds even more advancement of POC tests and devices including tests for cancer, molecular assays and phone enabled tests of all kinds.
Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care; especially since new technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation, or an electronic medical record.
This report breaks out point of care testing by segment.
Among the top and/or innovative competitors discussed within Corporate Profiles are:
- 1 Step Detect Associates
- Abaxis
- Abbott Labs
- Abingdon Health
- Access Bio
- ACON Laboratories
- Aerscher Diagnostics
- Akers Biosciences
- Alfa Scientific Designs
- American Bio Medica
- Arkray
- Arlington Scientific
- Artron Laboratories
- Ascensia Diabetes Care
- Ativa Medical Corp
- Atlas Link Biotech
- Audit Diagnostics
- Augurix Diagnostic
- Autobio Diagnostics
- Axxin
- Beckman Coulter
- Becton Dickinson
- Beijing Wantai Biological Pharmaceuticals
- Bhat Bio-Tech India Private Ltd.
- Binx health
- bioLytical Laboratories
- BioMedomics
- Biomeme
- Biomerica
- And Scores of Other Companies
Table of Contents
646 Pages
- Introduction
- Scope and Methodology
- Size and Growth of the Market
- Trends Affecting the Market
- Competitive Outlook
- Market Conclusions
- Point-of-Care Diagnostics Testing
- Industry Regulations
- POC Industry Drivers
- POC Test Types
- Conditions Evaluated by POC Diagnostic Testing
- Types of Blood Glucose Testing
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Types of Blood and Electrolytes Tests
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Overview
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Products
- Market Size and Growth
- COVID-19 Impact
- Competitive Analysis
- Microbiology
- TSH
- Allergy
- Autoimmune
- Others
- Market Size and Growth
- COVID-19 Impact
- Overview
- Wearables
- Mobile Healthcare Technologies
- Telehealth
- Patient-centered Healthcare
- Breath Test Advances
- Regulatory Hurdles
- Reimbursement Challenges
- PAMA
- Competition
- POC and Molecular Diagnostics
- Funding Developments in POC
- POC and Biosensors and Microfluidics
- China as a POC Market
- Emerging POC Technologies
- POC Connectivity
- Multiplexed POC Testing
- The Emergence of Non-invasive Technologies
- POC and Antibiotic Resistance Concern
- Market Overview
- Market Analysis by Product Categories
- Market Analysis by Subcategory
- Market by Device Technology
- Market Analysis by Country
- COVID-19 Impact
- Competitive Analysis
- Overview
- 1 Step Detect Associates, LLC
- Abaxis, Inc.
- Abbott Laboratories
- Abingdon Health, Ltd.
- AccessBio, Inc.
- AccuBioTech Co, Ltd.
- ACON Laboratories, Inc
- Aerscher Diagnostics, LLC
- Akers Biosciences, Inc.
- Alfa Scientific Designs, Inc
- American Bio Medica Corporation
- Arlington Scientific, Inc.
- Arkray, Inc.
- Artron Laboratories, Inc
- Ascensia Diabetes Care Holdings AG
- Atlas Link Biotech Co., Ltd
- Ativa Medical Corporation
- Audit Diagnostics
- Autobio Diagnostics Co., Ltd
- Augurix Diagnostic
- Axxin
- Beckman Coulter, Inc
- Becton Dickinson (BD)
- Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Bhat Bio-Tech India Private Ltd. (BBI)
- binx health
- bioLytical Laboratories
- Biomerica, Inc.
- BioMedomics, Inc
- Biomeme, Inc
- bioMerieux SA
- Biophor Diagnostics, Inc
- Bio-Rad Laboratories Inc.
- Biotron Diagnostics, Inc.
- Biosensia Ltd.
- Boditech Med Inc
- Boson Biotech Co. Ltd
- BNTX Inc.
- Calypte Biomedical Corporation
- Cepheid, Inc
- Chembio Diagnostics, Inc.
- Church & Dwight Co. Inc
- Clarity Diagnostics, LLC
- Confirm Biosciences
- CTK Biotech, Inc.
- Danaher Corporation
- Dexcom, Inc
- DIALAB GmbH
- DiaSys Diagnostic Systems GmbH
- DxGen Corp.
- Diazyme Laboratories, Inc.
- DNA Electronics Ltd. (DNAe)
- Dragerwerk AG & Co. KGaA
- Dr. Fooke-Achterrath Laboratorien GmbH
- DRG International, Inc.
- Eiken Chemical Co Ltd.
- EKF Diagnostics Holdings plc
- ELITechGroup, Inc.
- Enterix, Inc. (Clinical Genomics)
- Eurobio Scientific
- Eurolyser Diagnostica GmbH
- Everlywell
- Exact Sciences
- EY Laboratories
- Fio Corporation
- First Check Diagnostics LLC
- GenBio
- Genedrive plc
- GenePOC
- GeTein BioMedical, Inc.
- GlysBy snc
- Helena Laboratories
- Hemosure, Inc.
- HORIBA, Ltd.
- Immunosciences Lab, Inc.
- Immunostics, Inc
- InSilixa, Inc
- Instrumentation Laboratory
- JAL Innovation PTE LTD
- Jant Pharmacal Corporation
- J. Mitra & Co Pvt. Ltd
- LamdaGen Corporation
- LifeScan, Inc
- LifeSign, LLC
- Loop Medical
- Macherey-Nagel GmbH & Co. KG
- Magnasense Technologies
- MBio Diagnostics, Inc (LightDeck Diagnostics)
- Medix Biochemica
- MedMira, Inc
- Medtronic, Inc.
- A. Menarini Diagnostics srl.
- Meridian Bioscience, Inc
- MiCo BioMed USA
- Nano-Ditech Corporation
- NG Biotech
- Noble Medical, Inc
- Nova Biomedical Corp.
- NuGenerex Diagnostics
- Oasis Diagnostics Corporation
- Operon S.A.
- OPKO Health, Inc
- OPTI Medical Systems, Inc
- OraSure Technologies, Inc.
- Polymed Therapeutics Inc.
- Polymedco, Inc
- Polymer Technologies, Inc (PTS Diagnostics)
- Preventis GmbH
- Princeton Biomeditech Corporation
- QuantuMDx Group Limited
- Quidel Corporation
- Radiometer Medical A/S
- Randox Laboratories Limited
- RENESA UG
- Response Biomedical Corp
- Reszon Diagnostics International Sdn. Bhd.
- Rheonix, Inc
- Roche Diagnostic Corporation
- Savyon Diagnostics
- Sekisui Diagnostics LLC
- Siemens Healthineers GmbH
- Spectral Medical, Inc
- Sysmex Corporation
- TECHLAB, Inc.
- Teco Diagnostics
- Trinity Biotech PLC
- Trividia Health
- Tulip Diagnostics Ltd
- VedaLab
- Veredus Laboratories PTE Ltd
- Vircell
- WAMA Diagnostica
- Wave 80 Biosciences
- Werfen
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.